The influence of the hinge region length in binding of human IgG to human Fcγ receptors

Human Immunology

Volumn 59, Issue 11, 1998, Pages 720-727

  Redpath, Stella ^a,d   Michaelsen, Terje E ^b   Sandlie, Inger ^c   Clark, Michael R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; CELL LINE; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTIGENS, NEOPLASM; BINDING, COMPETITIVE; CELL LINE; DIMERIZATION; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RATS; RECEPTORS, IGG; SEQUENCE DELETION; TRANSFECTION;

EID: 0031688616     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00075-5     Document Type: Article

References (33)

1. Bruggeman M. Evolution of the rat Ig γ heavy chain gene family. Gene. 74:1988;473.
2. Warr G.W., Magor K.E., Higgins D.A. IgY-clues to the origins of modern antibodies. Immunol Today. 16:1995;392.
3. Pumphrey R.S.H. Computer models of human IgG. Immunol Today. 7:1986;206.
4. Dangl J.L., Wensel T.G., Morrison S.L., Stryer L., Herzenberg L.A., Oi V.T. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7:1988;1989.
5. Roux K.H., Strelets L., Michaelsen T.E. Flexibility of human IgG subclasses. J Immunol. 159:1997;3372.
6. Burton D.R., Woof J.M. Human antibody effector function. Adv Immunol. 51:1992;1.
7. Michaelsen T.E., Aase A., Westby C., Sandlie I. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons. Scand J Immunol. 32:1990;162.
8. Michaelsen T.E. ADCC induced by chimeric mouse-human IgG subclass and IgG3 antibodies with reduced hinge region. Mol Immunol. 30:1992;35.
9. Van de Winkel J.G., Capel P.J. Human IgG Fc receptor heterogeneity molecular aspects and clinical implications . Immunology Today. 14:1993;215.
10. Lund J., Winter G., Jones P., Pound J.D., Tanaka T., Walker M.R., Artmiuk P.J., Burton D.R., Jefferis R., Woof J.M. Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J Immunol. 147:1991;2657.
11. Allen J.M., Seed B. Isolation and expression of functional high affinity Fc receptor complementary DNAs. Science. 243:1989;378.
12. Socolovsky M., Hockaday A.R., Allen J.M. Human high affinity Fc IgG receptor (FcγRI) mediated phagocytosis and pinocytosis in COS cells. Eur J Cell Biol. 64:1994;29.
13. Riechmann L., Clark M.R., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 332:1988;323.
14. Redpath S: Effector functions of human IgG. PhD Thesis. University of Cambridge UK, 1995.
15. Isaacs J.D., Clark M.R., Greenwood J., Waldmann H. Therapy with monoclonal antibodies An in-vivo model for the assessment of therapeutic potential . J Immunol. 148:1992;3062.
16. Downie P.J., Voak D., Jarvis J., Waldmann H., Sptiz M. Use of monoclonal antibodies to human IgG in blood transfusion serology. Bio Bull. 4:1983;348.
17. Parham P, Androlewicz, Holmes NJ, Ways JP: Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods 53:133, 1982.
18. Parham P. On the fragmentation of monoclonal IgG1, IgG2a and IgG2b from Balb/c mice. J Immunol. 131:1983;2895.
19. Greenwood J., Gorman S.D., Routledge E.G., Lloyd I.S., Waldmann H. Engineering multiple domain forms of the therapeutic antibody CAMPATH 1H effects on complement lysis . Ther Immunol. 1:1994;247.
20. Ravetch J.V., Kinet J.P. Fc Receptors. Annu Rev Immunol. 9:1991;4573.
21. Clark M.R. IgG effector mechanisms. Chem Immunol. 65:1997;88.
22. Parren P., Warmerdam P., Boeije L., Arts J., Westerdaal N., Vlug A., Capel P.J.A., Aerdern L., van de Winkel J.G.J. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils and platelets. J Clin Invest. 90:1992;1537.
23. Duncan A.R., Woof J.M., Partridge L.J., Burton D.R., Winter G. Localization of the binding site for the human high affinity FcR on IgG. Nature. 332:1988;563.
24. Chappel M.S., Isenman D.E., Meverett T., Xu Y., Dorrington K.J., Klein M.H. Identification of the FcγRI binding site in human IgG through the use of recombinant IgG1/IgG2 hydrid and point mutated antibodies. Proc Natl Acad Sci USA. 88:1991;9036.
25. H2 domain and is modulated by the hinge region. J Exp Med. 173:1994;1483.
26. Jefferies R., Lund J., Pound J. Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR). Mol Immunol. 27:1990;1237.
27. Sarmay G., Lund J., Rozsnyay Z., Gergely J., Jefferis R. Mapping and comparison of the interaciton sites on the Fc region of the IgG responsible for the triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human FcγR receptor. Mol Immunol. 29:1992;633.
28. van de Winkel J.G.J., Tax W.J.M., van Bruggen M.C.J., van Roozendaal C.E.P., Willem W.J., van Diujnhoven J.L.P., Capel P.A., Koene R.A.P. A new photometric method for the quantitation of Fc receptors for murine IgG1 on human monocytes and cell lines. J Immunol Methods. 101:1987;109.
29. Tuijnman W.B., Capel P.J.A., van de Winkel J.G.J. A flow cytometric rosetting assay for the analysis of IgG-Fc receptor interactions. J Immunol Methods. 127:1990;207.
30. Gilliland L: 1988. PhD Thesis, University of Cambridge UK.
31. Gilliland L., Clark M.R., Waldman H. Universal bispecific antibodies for targeting tumor cells for destruction by cytotoxic T cells. Proc Natl Acad Sci USA. 85:1988;7719.
32. Hale G., Clark M., Waldman H. Therapeutic potential of rat monoclonal antibodies isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes . J Immunol. 134:1985;3056.
33. Greenwood J., Clark M., Waldman H. Structural motifs involved in human IgG antibody effector functions. Eur J Immunol. 23:1993;1098.